Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 36 non-cytoplasmic 37 54 transmembrane 55 65 cytoplasmic 66 84 transmembrane 85 89 non-cytoplasmic 90 109 transmembrane 110 114 cytoplasmic 115 133 transmembrane 134 162 non-cytoplasmic 163 185 transmembrane 186 212 cytoplasmic 213 238 transmembrane 239 249 cytoplasmic 250 256 non-cytoplasmic 257 277 transmembrane 278 286 non-cytoplasmic 287 309 transmembrane 310 327 cytoplasmic 328 330 non-cytoplasmic 331 348 transmembrane 349 352 non-cytoplasmic 353 369 transmembrane 370 373 cytoplasmic 374 394 transmembrane 395 399 non-cytoplasmic 400 419 transmembrane 420 439 cytoplasmic 440 460 transmembrane 461 464 non-cytoplasmic 465 492 transmembrane 493 497 cytoplasmic 498 527 transmembrane 528 532 non-cytoplasmic 533 553 transmembrane 554 564 cytoplasmic 565 584 transmembrane 585 598 non-cytoplasmic 599 624 transmembrane 625 632 cytoplasmic
Input: >WP_013010475.1 NCBI__GCF_000025725.1:WP_013010475.1 MYADLKKFEKIIFDIAAVFLVLFYSYAALIKPVSTEYHKGIYVFITYFLIFLVYKSKNKW LRIIDYILILAACVPVLYFMIFFVDLNYRAGAETIMDQWMSVVGVLMGIEVARRAVGSVF VLLGGAMILYGVFGDKVPDLFQHSGGNFLDTISVAIFLTNDGVFGIMADVLATYVLLFVL FGAFLEKSGAQKFFIDLPLAAVGHKTGGPAKVAVIASAIFGSISGSAIANTVSTGAFTIP LMKKAGFKPHVAGAVEPAASIGGMFMPPIMGAGGFIMAELTEVPYQTIMLVAIFPALMYF FSVFVMVHYEAKLHNIRGEKSAVSPKQIFKEGWHYVMPLVLITILMIMGKSPGYSAVVGM LSCVIITWTRGSKYVSIFTIVLLGVLFADSVKGFDSVNEMSAGLSTLVTFGFAALRGELR INLKEFIEASRNGTESSLKIGATVGVIGIIISMLTYSGLTLTFSSIIIHLAAGKLWLTIL LIALASLVLGMGVPVTAAYLITAVVAVPALTELGVSPIAAHMVVYWLSQDSNITPPVCIA AFAGATIAKANMWLTAFNAFKFAKFLYLGPFLFAYVPAFSMRHYLPGSDSYEWFSPTTIT LTFIAVIIGNYIFSYILSFHWIVLFKKKKQPA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server